Global Nucleic Acid Amplification Testing Market Size to grow at a CAGR of 8.13% by 2032, Evaluates DelveInsight

According to DelveInsight's analysis, The increasing demand for nucleic acid amplification testing (NAAT) is being fueled by several major factors, most notably the growing prevalence of infectious and genetic disorders. This demand is further strengthened by the rising number of cancer cases and the expanding R&D efforts undertaken by key industry participants. Together, these elements are expected to support a strong growth outlook for the NAAT market during the forecast period from 2025 to 2032.

DelveInsight's "Nucleic Acid Amplification Testing Market Insights, Competitive Landscape and Market Forecast-2032" report provides the current and forecast market outlook, forthcoming device innovation, challenges, market drivers and barriers. The report also covers the major emerging products and key Nucleic Acid Amplification Testing companies actively working in the market.

To know more about why North America is leading the market growth in the Nucleic Acid Amplification Testing market, get a snapshot of the report Nucleic Acid Amplification Testing Market Trends
https://www.delveinsight.com/sample-request/nucleic-acid-amplification-testing-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Nucleic Acid Amplification Testing Overview
Nucleic Acid Amplification Testing (NAAT) is a highly sensitive laboratory technique used to detect the genetic material (DNA or RNA) of pathogens such as viruses, bacteria, and parasites. By amplifying small amounts of nucleic acids, NAAT can identify infections even at very early stages when pathogen levels are low. It is widely used for diagnosing diseases like COVID-19, HIV, tuberculosis, and sexually transmitted infections. NAAT offers rapid, accurate, and reliable detection, making it a crucial tool in modern clinical diagnostics and public health surveillance.

DelveInsight Analysis: The nucleic acid amplification testing (NAAT) market size is projected to expand at a CAGR of 8.13% throughout the forecast period from 2025 to 2032.

Nucleic Acid Amplification Testing Market Insights
Geographically, North America has emerged as the dominant region in the nucleic acid amplification testing (NAAT) market. This leadership is largely driven by the growing prevalence of infectious and genetic disorders across the region. Polymerase chain reaction (PCR), a fundamental NAAT technology, serves as a highly reliable diagnostic method for identifying these conditions, especially when symptoms overlap or when multiple pathogens may be involved. As a result, the rising burden of infectious and genetic diseases is anticipated to further propel the growth of the NAAT market in North America.

To read more about the latest highlights related to Nucleic Acid Amplification Testing, get a snapshot of the key highlights entailed in the Nucleic Acid Amplification Testing Insights
https://www.delveinsight.com/report-store/nucleic-acid-amplification-testing-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Recent Developments in the Nucleic Acid Amplification Testing Market Report
• In May 2024, bioMérieux forged a strategic collaboration with AnaBioTec, an esteemed analytical service provider catering to the pharmaceutical, biopharmaceutical, and cell-based drug sectors across all stages of development. Together, these entities aim to revolutionize and elevate Mycoplasma testing standards within the biopharmaceutical and Cell & Gene Therapy (CGT) industries, specifically in Europe.
• In January 2021, Thermo Fisher Scientific Inc. successfully finalized the acquisition of Mesa Biotech, Inc. for a total of USD 450 million. This strategic move significantly enriched Thermo Fisher's product portfolio, particularly enhancing its offerings in PCR-based rapid point-of-care testing. Mesa Biotech specializes in molecular diagnostics and is renowned for its pioneering work in PCR-based infectious disease testing. Through this acquisition, Thermo Fisher is poised to expand its capabilities in detecting a range of infectious diseases, including but not limited to SARS-CoV-2, Influenza A and B, respiratory syncytial virus (RSV), and Strep A.
• Thus, owing to such developments in the market, rapid growth will be observed in the Nucleic Acid Amplification Testing market during the forecast period

Key Players in the Nucleic Acid Amplification Testing Market
Some of the key market players operating in the Nucleic Acid Amplification Testing market include- Abbott Laboratories, Agilent Technologies, Inc., Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd, Merck & Co., Inc., PerkinElmer Inc., Sysmex Corporation, Bio-Rad Laboratories, Inc., Seegene Inc., QIAGEN, bioMérieux, BD, Hologic, Inc., SHERLOCK BIOSCIENCES, Siemens Healthineers AG, Illumina, Inc., Danaher Corporation, Grifols, Meridian Bioscience, Inc., QuidelOrtho Corporation, and others.

Which MedTech key players in the Nucleic Acid Amplification Testing market are set to emerge as the trendsetter explore @ Key Nucleic Acid Amplification Testing Companies
https://www.delveinsight.com/sample-request/nucleic-acid-amplification-testing-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Analysis on the Nucleic Acid Amplification Testing Market Landscape
Technological progress and new product introductions are further accelerating the segment's expansion. In February 2023, bioMérieux, a biotechnology company based in France, launched the R-GENE PCR kit for monkeypox virus detection. The kit is compatible with a range of laboratory nucleic acid extraction and amplification systems, improving its ease of use and accessibility. Likewise, in April 2024, Bio-Rad Laboratories, Inc., a U.S.-based clinical diagnostics and life sciences company, unveiled the ddPLEX ESR1 Mutation Detection Kit-its first ultrasensitive multiplexed digital PCR assay-enhancing the company's Droplet Digital PCR (ddPCRTM) portfolio and supporting oncology research. These advanced mutation detection tools are essential for translational research, treatment selection, and disease monitoring.
Beyond infectious disease diagnostics, PCR methods are widely used by clinicians and researchers for gene cloning, sequencing, and high-precision genomic studies due to their speed and exceptional sensitivity. With its extensive applications and continuous technological advancements, the PCR testing segment is expected to play a substantial role in driving the nucleic acid amplification testing market throughout the forecast period.

Scope of the Nucleic Acid Amplification Testing Market Report
• Coverage: Global
• Study Period: 2022-2032
• Nucleic Acid Amplification Testing Market Segmentation By Product Type: Instruments and Reagents & Kits
• Nucleic Acid Amplification Testing Market Segmentation By Technology: Polymerase Chain Reaction (PCR) Testing, Isothermal Nucleic Acid Amplification Technology (INAAT), Transcription Mediated Amplification (TMA), CRISPER, and Others
• Nucleic Acid Amplification Testing Market Segmentation By Application: Infectious Disease Testing, Genetic Testing, Oncology Testing, and Others
• Nucleic Acid Amplification Testing Market Segmentation By End-User: Hospitals and Clinics, Diagnostic Centers, Academic and Research Institutes, and Others
• Nucleic Acid Amplification Testing Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of the World
• Key Nucleic Acid Amplification Testing Companies: Abbott Laboratories, Agilent Technologies, Inc., Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd, Merck & Co., Inc., PerkinElmer Inc., Sysmex Corporation, Bio-Rad Laboratories, Inc., Seegene Inc., QIAGEN, bioMérieux, BD, Hologic, Inc., SHERLOCK BIOSCIENCES, Siemens Healthineers AG, Illumina, Inc., Danaher Corporation, Grifols, Meridian Bioscience, Inc., QuidelOrtho Corporation, and others
• Porter's Five Forces Analysis, Product Profiles, Case Studies, KOL's Views, Analyst's View

Interested in knowing how the Nucleic Acid Amplification Testing market will grow by 2032? Click to get a snapshot of the Nucleic Acid Amplification Testing Market Analysis
https://www.delveinsight.com/sample-request/nucleic-acid-amplification-testing-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Contact Us
Gaurav Bora
info@delveinsight.com
+14699457679
www.delveinsight.com

About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing end-to-end comprehensive solutions to improve their performance.
Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.

This release was published on openPR.